1912TiP STELLAR-304: A randomized phase III study of zanzalintinib (XL092) and nivolumab in non-clear cell renal cell carcinoma (nccRCC)
- Resource Type
- Abstract
- Source
- In
Annals of Oncology October 2023 34 Supplement 2:S1028-S1029 - Subject
- Language
- ISSN
- 0923-7534